Full text is available at the source.
Abstract
Gut microbiota modulation strategies may enhance cancer immunotherapy outcomes.
- The gut microbiota is associated with regulating immune functions and metabolic processes critical for health.
- Immune checkpoint inhibitors (ICIs) can face challenges such as treatment resistance and immune-related adverse events.
- Evidence from mouse models and clinical trials suggests that manipulating gut microbiota could improve ICI effectiveness.
- Strategies like fecal microbiota transplantation and dietary interventions may help optimize therapeutic outcomes and reduce adverse effects.
- Gut microbiota influence immune responses by affecting various immune system components and mechanisms.
Simplified